| 000 | 01576 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517150352.0 | ||
| 264 | 0 | _c20180321 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1559-6834 | ||
| 024 | 7 |
_a10.1017/ice.2017.48 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCannon, Cara M | |
| 245 | 0 | 0 |
_aRisk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile. _h[electronic resource] |
| 260 |
_bInfection control and hospital epidemiology _c06 2017 |
||
| 300 |
_a718-720 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCarrier State _xdiagnosis |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 | _aClostridioides difficile |
| 650 | 0 | 4 |
_aEnterocolitis, Pseudomembranous _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematologic Neoplasms _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPatient Admission |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aMusuuza, Jackson S | |
| 700 | 1 | _aBarker, Anna K | |
| 700 | 1 | _aDuster, Megan | |
| 700 | 1 | _aJuckett, Mark B | |
| 700 | 1 | _aPop-Vicas, Aurora E | |
| 700 | 1 | _aSafdar, Nasia | |
| 773 | 0 |
_tInfection control and hospital epidemiology _gvol. 38 _gno. 6 _gp. 718-720 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1017/ice.2017.48 _zAvailable from publisher's website |
| 999 |
_c27069465 _d27069465 |
||